WelChol® and Insulin in Treating Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Type 2 Diabetes
Interventions
DRUG

Colesevelam hydrochloride

Trial Locations (47)

Unknown

Tuscumbia

Sierra Vista

Jonesboro

Searcy

Carmichael

Concord

Fullerton

La Jolla

San Diego

West Hills

Washington D.C.

Largo

Miami

New Port Richey

West Palm Beach

Chicago

Indianapolis

Lexington

Louisville

New Orleans

Boston

Troy

Edina

Chesterfield

Kansas City

St Louis

Bozeman

Butte

Englewood

Charlotte

Hickory

Raleigh

Statesville

Winston-Salem

Cincinnati

Marion

Portland

Beaver

Charleston

Bristol

Morristown

Dallas

Houston

Midland

San Antonio

Mexico City

Lima

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY